Ionis Pharmaceuticals Inc. Stock
Ionis Pharmaceuticals Inc. gained 1.990% today.
The stock is one of the favorites of our community with 63 Buy predictions and 1 Sell predictions.
With a target price of 79 € there is a hugely positive potential of 61.72% for Ionis Pharmaceuticals Inc. compared to the current price of 48.85 €.
Our community identified positive and negative aspects for Ionis Pharmaceuticals Inc. stock for the coming years. 0 users see the criterium "Worthwhile Investment for the next years" as a plus for the Ionis Pharmaceuticals Inc. stock. On the other hand our users think that "Worthwhile Investment for the next years" could be a problem in the future.
Pros and Cons of Ionis Pharmaceuticals Inc. in the next few years
Pros
?
G***** c******* t* c**********
?
C******** o* t** e**********
?
B****
Cons
?
W********* I********* f** t** n*** y****
?
M***** P*******
?
S********** s********
Tell us your opinion to access the 'Wisdom of the Crowds'
Performance of Ionis Pharmaceuticals Inc. vs. its peers
| Security | Change(%) | 1w | 1m | 1y | YTD | 3y | 5y |
|---|---|---|---|---|---|---|---|
| Ionis Pharmaceuticals Inc. | 1.990% | 8.773% | -35.384% | 39.931% | -28.119% | 37.451% | 47.985% |
| Ligand Pharmaceuticals | -3.820% | -0.781% | -9.286% | 117.094% | 53.012% | 319.835% | 171.194% |
| United Therapeutics | -0.580% | 3.809% | -5.572% | 81.464% | 9.057% | 115.541% | 156.044% |
| Novocure Ltd | -1.440% | 3.029% | -10.168% | 39.281% | 20.026% | -47.532% | -89.342% |
Comments
Ionis Pharmaceuticals (IONS) had its price target raised by JPMorgan Chase & Co. from $72.00 to $76.00. They now have an "overweight" rating on the stock.
Show more
Ratings data for IONS provided by MarketBeat
Ionis Pharmaceuticals (IONS) had its price target lowered by Wells Fargo & Company from $100.00 to $95.00. They now have an "overweight" rating on the stock.
Show more
Ratings data for IONS provided by MarketBeat
Ionis Pharmaceuticals (IONS) had its price target lowered by HC Wainwright from $125.00 to $115.00. They now have a "buy" rating on the stock.
Show more
Ratings data for IONS provided by MarketBeat